Literature DB >> 7065902

Restriction of virus-specific protein synthesis in a persistent paramyxovirus infection.

S J Robbins, F Rapp.   

Abstract

Synthesis of virus-specific proteins in a persistent, nonproductive paramyxovirus infection derived from the peripheral blood leukocytes of a patient with subacute sclerosing panencephalitis (SSPE) was investigated. The persistently infected cells expressed cytoplasmic virus-specific antigens and generated paramyxovirus nucleocapsids throughout long-term passage. When analyzed by specific immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, most of the virus structural proteins were synthesized in acutely infected cells, but only three of the proteins could be readily detected in persistently infected cells. The two structural proteins whose synthesis was most clearly restricted had molecular weights of 69,000 and 41,000 daltons and represented the putative HN and M virus proteins. The similarities between the restriction of virus protein synthesis in this system and that reported previously for other persistent paramyxovirus infections derived from SSPE suggest that a common mechanism may be involved in the maintenance of such infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065902     DOI: 10.1007/bf01315178

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly.

Authors:  T Yoshida; S Nagai Y'Yoshii; K Maeno; T Matsumoto
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

2.  Encephalitis in ferrets caused by a nonproductive strain of measles virus (D.R.) isolated from patient with subacute sclerosing panencephalitis.

Authors:  H Thormar; K Arnesen; P D Mehta
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

3.  Regulatory events in the synthesis of Sendai virus polypeptides and their assembly into virions.

Authors:  A Portner; D W Kingsbury
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

4.  The transcriptase complex of the paramyxovirus SV5.

Authors:  E Buetti; P W Choppin
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Isolation and partial characterization of two forms of cytoplasmic nucleocapsids from measles virus-infected cells.

Authors:  S J Robbins; R H Bussell; F Rapp
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

7.  Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.

Authors:  W W Hall; R A Lamb; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Rescue of a cytopathic paramyxovirus from peripheral blood leukocytes in subacute sclerosing panencephalitis.

Authors:  S J Robbins; H Wrzos; A L Kline; R B Tenser; F Rapp
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Absence of M protein in a cell-associated subacute sclerosing panencephalitis virus.

Authors:  F H Lin; H Thormar
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

10.  Persistent infection of BSC-1 cells by defective measles virus derived from subacute sclerosing panencephalitis.

Authors:  T Burnstein; L B Jacobsen; W Zeman; T T Chen
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  2 in total

1.  Characterization of human parainfluenza virus type 3 persistent infection in cell culture.

Authors:  A Moscona; M S Galinski
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Evolution of in vitro persistence of two strains of canine parainfluenza virus. Brief report.

Authors:  W Baumgärtner; S Krakowka; J Blakeslee
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.